Published in J Invest Dermatol on November 01, 2008
Immunotherapy for melanoma: current status and perspectives. J Immunother (2010) 1.72
The environmental stressor ultraviolet B radiation inhibits murine antitumor immunity through its ability to generate platelet-activating factor agonists. Carcinogenesis (2012) 1.05
Chemotherapeutic agents subvert tumor immunity by generating agonists of platelet-activating factor. Cancer Res (2014) 0.97
Toll-like receptors: role in dermatological disease. Mediators Inflamm (2010) 0.93
Fine analysis of spontaneous MAGE-C1/CT7-specific immunity in melanoma patients. Proc Natl Acad Sci U S A (2010) 0.89
Adoptive immunotherapy with Cl-IB-MECA-treated CD8+ T cells reduces melanoma growth in mice. PLoS One (2012) 0.89
Effective melanoma immunotherapy in mice by the skin-depigmenting agent monobenzone and the adjuvants imiquimod and CpG. PLoS One (2010) 0.88
Cancer immunotherapy takes a multi-faceted approach to kick the immune system into gear. Yale J Biol Med (2011) 0.88
The importance of the age factor in cancer vaccination at older age. Cancer Immunol Immunother (2009) 0.86
Major histocompatibility complex class II+ invariant chain negative breast cancer cells present unique peptides that activate tumor-specific T cells from breast cancer patients. Mol Cell Proteomics (2012) 0.85
Enhancing the immunogenicity of tumour lysate-loaded dendritic cell vaccines by conjugation to virus-like particles. Br J Cancer (2011) 0.82
DC-HIL-expressing myelomonocytic cells are critical promoters of melanoma growth. J Invest Dermatol (2014) 0.81
Value of large scale expansion of tumor infiltrating lymphocytes in a compartmentalised gas-permeable bag: interests for adoptive immunotherapy. J Transl Med (2011) 0.80
Immunohistochemical Analysis of Collagen IV and Laminin Expression in Spontaneous Melanoma Regression in the Melanoma-Bearing Libechov Minipig. Acta Histochem Cytochem (2015) 0.79
Treatment of unresectable stage IV metastatic melanoma with aviscumine after anti-neoplastic treatment failure: a phase II, multi-centre study. J Immunother Cancer (2014) 0.76
Tumor vessel-injuring ability improves antitumor effect of cytotoxic T lymphocytes in adoptive immunotherapy. Cancer Gene Ther (2012) 0.76
Absence of CD4 T-cell help provides a robust CD8 T-cell response while inducing effective memory in a preclinical model of melanoma. Immunotherapy (2012) 0.76
IL-10: Expanding the Immune Oncology Horizon. Receptors Clin Investig (2015) 0.75
Targeting myeloid derived suppressor cells with all-trans retinoic acid is highly time-dependent in therapeutic tumor vaccination. Oncoimmunology (2017) 0.75
Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. Proc Natl Acad Sci U S A (2005) 5.21
Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model. Proc Natl Acad Sci U S A (2009) 2.41
Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res (2002) 2.06
Chemokines, chemokine receptors, and cancer metastasis. J Leukoc Biol (2006) 2.03
CCR6 is required for IL-23-induced psoriasis-like inflammation in mice. J Clin Invest (2009) 1.65
Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases. Clin Exp Metastasis (2007) 1.63
CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via beta(1) integrin. Cancer Res (2003) 1.57
Immune evasion by murine melanoma mediated through CC chemokine receptor-10. J Exp Med (2003) 1.34
Chemokine receptors and melanoma metastasis. J Dermatol Sci (2004) 1.32
Epidermal CCR6+ γδ T cells are major producers of IL-22 and IL-17 in a murine model of psoriasiform dermatitis. J Immunol (2011) 1.24
Chemokine receptors as targets for cancer therapy. Curr Pharm Des (2009) 1.15
CCR6 is required for epidermal trafficking of γδ-T cells in an IL-23-induced model of psoriasiform dermatitis. J Invest Dermatol (2012) 1.08
Disruption of Id1 reveals major differences in angiogenesis between transplanted and autochthonous tumors. Cancer Cell (2003) 1.08
Sensitization of B16 tumor cells with a CXCR4 antagonist increases the efficacy of immunotherapy for established lung metastases. Mol Cancer Ther (2006) 1.07
Skin reactions in a subset of patients with stage IV melanoma treated with anti-cytotoxic T-lymphocyte antigen 4 monoclonal antibody as a single agent. Arch Dermatol (2006) 1.05
Selective expression of stromal-derived factor-1 in the capillary vascular endothelium plays a role in Kaposi sarcoma pathogenesis. Blood (2003) 1.03
A locked, dimeric CXCL12 variant effectively inhibits pulmonary metastasis of CXCR4-expressing melanoma cells due to enhanced serum stability. Mol Cancer Ther (2012) 1.02
Cutaneous T-cell lymphoma: roles for chemokines and chemokine receptors. J Invest Dermatol (2009) 0.94
Small numbers of residual tumor cells at the site of primary inoculation are critical for anti-tumor immunity following challenge at a secondary location. Cancer Immunol Immunother (2006) 0.93
Chemokine receptors in the pathogenesis and therapy of psoriasis. J Dermatol Sci (2011) 0.92
A novel function of junctional adhesion molecule-C in mediating melanoma cell metastasis. Cancer Res (2011) 0.92
Oncostatin M enhances CCL21 expression by microvascular endothelial cells and increases the efficiency of dendritic cell trafficking to lymph nodes. J Immunol (2006) 0.90
Cutting edge: rapid accumulation of epidermal CCL27 in skin-draining lymph nodes following topical application of a contact sensitizer recruits CCR10-expressing T cells. J Immunol (2008) 0.89
Intralymphatic dendritic cell vaccination induces tumor antigen-specific, skin-homing T lymphocytes. Clin Cancer Res (2006) 0.88
CCR7 regulates B16 murine melanoma cell tumorigenesis in skin. J Leukoc Biol (2008) 0.88
CCR6 as a possible therapeutic target in psoriasis. Expert Opin Ther Targets (2010) 0.88
Chemokine receptors in T-cell-mediated diseases of the skin. J Invest Dermatol (2009) 0.86
Inflammation and tumor microenvironment in lymph node metastasis. Cancers (Basel) (2011) 0.85
Upregulation of inflammatory cytokines and oncogenic signal pathways preceding tumor formation in a murine model of T-cell lymphoma in skin. J Invest Dermatol (2011) 0.85
CXCR5-transduced bone marrow-derived dendritic cells traffic to B cell zones of lymph nodes and modify antigen-specific immune responses. J Immunol (2002) 0.85
CXCR4 negatively regulates keratinocyte proliferation in IL-23-mediated psoriasiform dermatitis. J Invest Dermatol (2013) 0.83
Chemokine receptors in melanoma: CCR9 has a potential role in metastasis to the small bowel. J Invest Dermatol (2004) 0.82
Autosomal dominant epidermodysplasia verruciformis lacking a known EVER1 or EVER2 mutation. Pediatr Dermatol (2009) 0.80
Proteomic patterns for classification of ovarian cancer and CTCL serum samples utilizing peak pairs indicative of post-translational modifications. Proteomics (2007) 0.78
11. Allergic and immunologic diseases of the skin. J Allergy Clin Immunol (2003) 0.77
Paradoxical increase in skin inflammation in the absence of CCR4. J Invest Dermatol (2010) 0.77
CCR6 colocalizes with CD18 and enhances adhesion to activated endothelial cells in CCR6-transduced Jurkat T cells. J Immunol (2002) 0.77
Roles for CD30 in the biology and treatment of CD30 lymphoproliferative diseases. J Invest Dermatol (2004) 0.76
Zosteriform metastases of eccrine porocarcinoma mimicking eruptive seborrhoeic keratoses. Acta Derm Venereol (2015) 0.75
Genetic immunization with LYVE-1 cDNA yields function-blocking antibodies against native protein. Microvasc Res (2005) 0.75
T-cell clonality of peripheral blood lymphocytes in patients with lymphomatoid papulosis. J Am Acad Dermatol (2005) 0.75
56th annual Montagna Symposium on the Biology of Skin: Epidermal T-cell interactions--clinicopathological and basic mechanisms. J Invest Dermatol (2008) 0.75
Intertriginous orange-to-brownish papules and plaques: a quiz. Xanthoma disseminatum. Acta Derm Venereol (2013) 0.75
Erosive and mitotically active juvenile xanthogranuloma on the neck of an infant. J Dtsch Dermatol Ges (2014) 0.75